ADA and severe combined immunodeficiency: Gene therapy is a very promising treatment for adenosine deaminase severe combined immunodeficiency (ADA-SCID) [5-7], not only because the nature of the disorder makes the patient less likely to reject the vector, but also because it is a well characterized monogenic disorder.